Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medications Used to Treat Inflammatory Bowel Disease

An inflammatory bowel disease and drug technology, applied in the direction of drug combination, medical raw materials derived from mammals, antipyretics, etc., can solve the problem of no inflammatory bowel disease cellular immunotherapy method, etc., and achieve the effect of reducing intestinal inflammation

Active Publication Date: 2022-04-19
THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There is no prior art on cellular immunotherapy for the treatment of inflammatory bowel disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medications Used to Treat Inflammatory Bowel Disease
  • Medications Used to Treat Inflammatory Bowel Disease
  • Medications Used to Treat Inflammatory Bowel Disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 Using mice as a model to establish a method for DN T cells used in immunotherapy for inflammatory bowel disease

[0022] 1. The establishment process of IBD mouse model

[0023] Using dextran sulfate sodium (DSS) to induce the colitis model in mice, the mice were given water containing 3% (w / v) DSS for 7 days, and then changed to normal water for 1 day to construct mice Colitis model. The body weight and disease activity index (DAI) of mice were detected daily to evaluate the severity of colitis in mice. DAI score includes stool properties, rectal bleeding, etc.

[0024] 2. Reinfusion of DN T cells into the established mouse model

[0025] The method of DN T cells for immunotherapy of inflammatory bowel disease uses the following components: (1) specific fluorescent antibody for T cells; (2) medium (1640 medium with 10% fetal bovine serum); (3) Interleukin-2 (20ng / ml).

[0026] Specifically include the following steps:

[0027] S1. Take 20ml of periphera...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of immunotherapy and discloses a medicine for treating inflammatory bowel disease, wherein the medicine includes CD4-CD8-double-negative T cells. By constructing a mouse model of inflammatory bowel disease, then extracting autologous peripheral blood, isolating DN T cells, expanding and culturing in vitro, and then intravenously injecting back into the autologous body, the purpose of relieving and treating intestinal inflammation can be achieved. The present invention uses DN T cells and immunotherapy method thereof for the first time to realize immunotherapy for inflammatory bowel disease. The method has the advantages of reducing intestinal inflammation and the like, is suitable for comprehensive treatment of inflammatory bowel disease, and is suitable for clinical application.

Description

technical field [0001] The present invention specifically relates to the technical field of immunotherapy, and more specifically, to medicines for treating inflammatory bowel disease. Background technique [0002] Inflammatory bowel disease (Inflammatory bowel disease, IBD) is an autoimmune disease, which is a chronic idiopathic disease that occurs in the intestinal tract, requires life-long treatment and is incurable, with clinical characteristics of frequent relapses and remissions. In the past ten years, the number of patients with IBD in my country has gradually increased, and it will become a common disease of the digestive system in my country. Conventional drug therapies for IBD, such as anti-inflammatory agents, glucocorticoids, and immunosuppressants, are limited due to their systemic adverse effects and toxicity during long-term treatment. [0003] Cell therapy is to activate and expand autologous or allogeneic immune effector cells in vitro, and then infuse them ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K35/17A61P1/00A61P29/00
CPCA61K35/17A61P1/00A61P29/00
Inventor 黄曦王子晴洪海吴永坚
Owner THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products